Oral Session 2-13D MDS：Basic (3)

[OS2-13D-1] Integrated profiling of genetic and epigenetic alterations in patients with myeloid neoplasms

Suguru Morimoto¹, Hideki Makishima¹, Yasunobu Nagata¹, Constance Baer², Niroshan Nadarajah², Genta Nagae³, Yasuhito Nanya¹, Yasushi Miyazaki⁴, Malcovati Luca^5,6, Kenichi Yoshida¹, Tetsuichi Yoshizato¹, Masahiro Nakagawa¹, Ryosaku Inagaki¹, June Takeda¹, Yoichi Fujii¹, Yasuhide Takeuchi¹, Yotaro Ochi¹, Hiroo Ueno¹, Yuichi Shiraishi⁷, Kenichi Chiba⁷, Hiroko Tanaka⁸, Masashi Sanada⁹, Satoru Miyano^7,8, Claudia Haferlach², Wolfgang Kern², Hiroyuki Aburatani³, Cazzola Mario^5,6, Torsten Haferlach², Seishi Ogawa¹ (1.Department of Pathology and Tumor biology, Kyoto University, Kyoto, Japan, 2.MLL Munich Leukemia Laboratory, Munich, Germany, 3.Center for Advanced Science and Technology, 4.Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 5.Department of Molecular Medicine, University of Pavia, Pavia, Italy, 6.Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 7.Laboratory of Sequence Analysis, Human Genome Center, The Univ. of Tokyo, Tokyo, Japan, 8.Laboratory of DNA Information Analysis, Human Genome Center, The Univ. of Tokyo, Tokyo, Japan, 9.National Hospital Organization Nagoya Medical Center, Nagoya, Japan)